-

VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs

Botanical wellness leader supports decisive actions to get dangerous drugs out of hands of consumers and protect access to high-quality, natural botanical products

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, the nation’s leading botanical wellness company, welcomes the Drug Enforcement Administration’s (DEA) decision to classify 7-hydroxymitragynine (7-OH) and three related drugs as Schedule I drug. 7-OH is a dangerous synthetic, lab-made drug that HHS and FDA have described as harmful and addictive. 7-OH has raised serious concerns for public health and consumer safety. This move critically distinguishes these harmful synthetic drugs and the natural botanical kratom.

We commend the DEA and HHS for explicitly clarifying that their actions were not intended to regulate the natural botanical kratom, which does not contain any of the scheduled drugs.

Share

“The DEA decisively addressed the real, tangible risks associated with 7-OH drugs, making consumers safer and the marketplace more transparent,” said Bryan Derr, Chief Operating Officer of VIVAZEN®. “VIVAZEN® was built on a commitment to providing consumers with effective wellness solutions, innovating responsibly, and above all, prioritizing transparency and quality. This critical move makes it easier for VIVAZEN® to uphold these same commitments without worrying that consumers could be tricked by duplicitous drugs marketing themselves as safe wellness solutions rather than the dangerous synthetic drugs they are.”

The Company is pleased to see the administration recognize how harmful synthetic drugs like 7-OH and other dangerous lab-made unapproved drugs undermine consumer trust, threaten the integrity of the broader botanical and dietary supplement marketplace, and put responsible operators at a disadvantage. We commend the DEA and HHS for explicitly clarifying that their actions were not intended to regulate the natural botanical kratom, which does not contain any of the scheduled drugs.

For more than a decade, VIVAZEN® has worked to help build a category grounded in responsible manufacturing, rigorous quality standards, and scientific validation. As a functional wellness company that develops clinically tested, GMP-manufactured natural botanical products, VIVAZEN® maintains a strong belief that products that are masquerading as natural botanicals undermine consumer safety and trust.

Consumer Safety & Transparent Labelling

VIVAZEN® is committed to keeping consumers informed on what to lookout for to ensure their products of choice contain premium, science-backed botanicals like kratom.

  • Check the label: natural botanical kratom products will list Mitragyna speciosa leaf extract clearly on the label. VIVAZEN® will include any other active ingredients on the packaging so regulators, retailers, and consumers have access to transparent information.
  • Use as directed: consuming health and wellness products as directed, and in consultation with your healthcare provider, is an important part in realizing the full benefits and reducing potential adverse effects.
  • Look for a name you trust: VIVAZEN® products are designed with premium formulations that enhance an individual’s quality of life. The products – from liquids to gummies to capsules – vary to support any lifestyle so individuals can select offerings that seamlessly fit into routines without compromise.

The VIVAZEN® Commitment

VIVAZEN® products are formulated with safety and quality in mind. Each product undergoes third-party testing to ensure purity, strength, and compliance with our rigorous quality and safety standards. With increasing concerns about unlawful and potentially harmful products in the market, VIVAZEN® is committed to providing transparency and educating consumers on the responsible use of botanicals.

About VIVAZEN®

For over a decade, VIVAZEN® has delivered trusted, high-quality botanical supplements that provide people with functional wellness without compromise. Grounded in centuries of wellness practices and backed by modern innovation, VIVAZEN® products offer functional, feel-good alternatives for those who want to live — and feel — on their own terms. Join the millions who trust VIVAZEN® to Feel Great™ naturally. Visit us at www.vivazen.com.

Contacts

For media inquiries, please contact: Press@vivazen.com

VIVAZEN


Release Versions

Contacts

For media inquiries, please contact: Press@vivazen.com

More News From VIVAZEN

VIVAZEN® Urges Immediate Action on 7-OH as U.S. House of Representatives Examines End Needless Distribution of 7-OH Act

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, the nation’s leading botanical wellness company, welcomed congressional scrutiny of 7-hydroxymitragynine (7-OH) as the House Energy and Commerce Subcommittee on Health holds a legislative hearing on H.R. 8000, the End Needless Distribution of 7-OH Act, introduced by Representative Gus Bilirakis (R-FL) and related illicit-drug legislation. The hearing underscores growing concern in Washington about 7-OH, as members of the subcommittee called on the Drug Enforc...

Groundbreaking Clinical Study Reveals Promising Evidence for VIVAZEN®’s Kratom Extracts

PHOENIX--(BUSINESS WIRE)--VIVAZEN® proudly announces the results of a pioneering 28-day clinical study evaluating the safety and tolerability of its proprietary kratom extracts. The findings, presented by Dr. Jenelle Patterson of Gowling WLG, at the University of Florida Fifth Scientific Kratom Symposium, reinforce VIVAZEN®’s dedication to advancing knowledge in botanical wellness through rigorous scientific research. The study assessed the effects of VIVAZEN®’s proprietary kratom extract on ad...

VIVAZEN® Applauds Kentucky’s Leadership in Protecting Consumers from Synthetic 7-Hydroxymitragynine (7-OH)

PHOENIX--(BUSINESS WIRE)--VIVAZEN®, a leading botanical wellness company specializing in natural, full-spectrum kratom products, expressed strong support for Kentucky Governor Andy Beshear and Health and Family Services Secretary Dr. Steven Stack following the announcement that the state will move to classify isolated and concentrated forms of 7-hydroxymitragynine (7-OH) as Schedule I narcotics. Governor Beshear’s action will make it illegal to sell or distribute products containing synthetic o...
Back to Newsroom